The Coca-Cola Co K vs Teladoc Health Inc — how do they compare? The Coca-Cola Co K trades at $88.05 (market cap $377.63B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: The Coca-Cola Co K is far larger — about 373.9× Teladoc Health Inc's market cap, and The Coca-Cola Co K pays a 2.42% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold The Coca-Cola Co K for 154 Days and Teladoc Health Inc for 39 Days on average.
| KO | TDOC | |
|---|---|---|
Market Cap | $377.63B | $1.01B |
Volume | 14,894,568 | 4,668,477 |
Sector | Consumer Staples | Health |
52-Week High | $91.99 | $9.72 |
52-Week Low | $66.80 | $4.47 |
Typical Hold Time | 154 Days | 39 Days |
Enterprise Value | $404.81B | $1.27B |
Dividend Yield | 2.42% | — |
Signals from Pluang's Aura AI — not financial advice
Coca-Cola (KO) trades at $87.77, up 2.27% today, with a bullish technical signal from moving averages and a strong fundamental profile. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $0.97 surpassing the $0.92 estimate. Revenue reached $47.94B in 2025, with net income margin improving to 28.56%. The company maintains a robust balance sheet with $14.57B in cash and a 64-year dividend growth streak, supported by steady cash flow from operations.
The outlook remains positive, supported by analyst consensus with a $95.75 price target and 60% buy ratings. Key opportunities include stable global demand and brand strength, while risks involve regional volume divergence and high valuation multiples. Long-term investors may find value in its defensive qualities and dividend reliability, though near-term volatility could persist amid macroeconomic uncertainties.
TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.
The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →